Institut Curie
47 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 8 name spellings.
14
Ending by 2030
Apr 2028
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Nov 16, 2026
- 2 fees due Feb 18 to 28, 2027 · next Feb 18
- 2 fees due Jul 12 to 21, 2027 · next Jul 12
Recent changes
- 3 of the patents on this record were granted since Aug 16, 2026
- 3 terms have ended since Aug 16, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,932,339 | Novel Method for Producing Water-Soluble Comb-Shaped Copolymers In force · High confidence | In force | High confidence | |
| US 7,955,838 | Methods and Device for Adhesive Control of Internal Cell Organisation In force · High confidence | In force | High confidence | |
| US 10,130,595 | Chemical Molecules That Inhibit the Slicing Mechanism for Treating Diseases Resulting from Splicing Anomalies In force · High confidence | In force | High confidence | |
| US 10,654,813 | Chemical Molecules That Inhibit the Slicing Mechanism for Treating Diseases Resulting from Splicing Anomalies In force · High confidence | In force | High confidence | |
| US 9,233,931 | Chemical Molecules That Inhibit the Slicing Mechanism for Treating Diseases Resulting from Splicing Anomalies In force · High confidence | In force | High confidence | |
| US 9,566,558 | Device for Manipulation of Packets in Micro-Containers, in Particular in Microchannels In force · High confidence | In force | High confidence | |
| US 8,425,879 | Metalloporphyrin Derivatives, Nanoparticles Comprising the Same, and Use Thereof for Photodynamic Therapy In force · High confidence | In force | High confidence | |
| US 9,108,919 | Compounds Useful for Treating Cancer In force · Medium confidence | In force | Medium confidence | |
| US 9,637,475 | Compounds for Treating Cancer In force · Medium confidence | In force | Medium confidence | |
| US 10,017,498 | Compounds Useful for Treating Aids In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 57: 47 patents in force now held by others · 72 lapsed for an unpaid fee · 23 ended at full term · 2 past the fee grace period. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
62 pending · 81 abandoned · 20 no status recorded